Abstract
Construction of safe and effective delivery systems for proteins and peptides is demand of current clinical practices. Biodegradable polymers based particulates carriers fulfill much of the requirement in this applicable field. Number of marketed products related to biodegradable polymers encapsulating proteins is increasing. However, it has not achieved its proper place since problems related to the protein processing and stabilization limits the scientific community. In this present review we have summarized various aspects related to the formulation and processing of biodegradable polymerized microparticles/ nanoparticles for delivery of therapeutic proteins and peptides. A brief introduction of biodegradable polymers has been incorporated for readers benefit. In addition, biodegradable polymers based carriers designed for vaccine delivery has been incorporated in detail. Functionalized biodegradable carrier(s) for site specific delivery of proteineous matter has also been discussed.
Keywords: Biodegradable polymers, protein, peptide, vaccine, microparticles, nanoparticles, lectins, poloxamer, PEGylation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Biodegradable Polymer Based Particulate Carrier(s) for the Delivery of Proteins and Peptides
Volume: 7 Issue: 4
Author(s): Neeraj Mishra, Amit K. Goyal, Kapil Khatri, Bhuvaneshwar Vaidya, Rishi Paliwal, Shivani Rai, Abhinav Mehta, Shailja Tiwari, Shiva Vyas and Suresh P. Vyas
Affiliation:
Keywords: Biodegradable polymers, protein, peptide, vaccine, microparticles, nanoparticles, lectins, poloxamer, PEGylation
Abstract: Construction of safe and effective delivery systems for proteins and peptides is demand of current clinical practices. Biodegradable polymers based particulates carriers fulfill much of the requirement in this applicable field. Number of marketed products related to biodegradable polymers encapsulating proteins is increasing. However, it has not achieved its proper place since problems related to the protein processing and stabilization limits the scientific community. In this present review we have summarized various aspects related to the formulation and processing of biodegradable polymerized microparticles/ nanoparticles for delivery of therapeutic proteins and peptides. A brief introduction of biodegradable polymers has been incorporated for readers benefit. In addition, biodegradable polymers based carriers designed for vaccine delivery has been incorporated in detail. Functionalized biodegradable carrier(s) for site specific delivery of proteineous matter has also been discussed.
Export Options
About this article
Cite this article as:
Mishra Neeraj, Goyal K. Amit, Khatri Kapil, Vaidya Bhuvaneshwar, Paliwal Rishi, Rai Shivani, Mehta Abhinav, Tiwari Shailja, Vyas Shiva and Vyas P. Suresh, Biodegradable Polymer Based Particulate Carrier(s) for the Delivery of Proteins and Peptides, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (4) . https://dx.doi.org/10.2174/187152308786847816
DOI https://dx.doi.org/10.2174/187152308786847816 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Butyrylcholinesterase K and Apolipoprotein ε4 Affect Cortical Thickness and Neuropsychiatric Symptoms in Alzheimer’s Disease
Current Alzheimer Research Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS
Current Topics in Medicinal Chemistry Drug Targets for Rational Design against Emerging Coronaviruses
Infectious Disorders - Drug Targets Herpes Simplex Encephalitis: From Virus to Therapy
Infectious Disorders - Drug Targets Editorial (Thematic Issue: The Monocyte/Macrophage in the Pathogenesis of AIDS: The Next Frontier for Therapeutic Intervention in the CNS and Beyond: Part II)
Current HIV Research Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Monoclonal Antibodies Against Viruses and Bacteria: A Survey of Patents
Recent Patents on Anti-Infective Drug Discovery Regulation of Protective and Pathogenic Th17 Responses
Current Immunology Reviews (Discontinued) Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier
Current Drug Metabolism Differential Regulation of Neurotoxin in HIV Clades: Role of Cocaine and Methamphetamine
Current HIV Research HIV-1 Capsid Inhibitors as Antiretroviral Agents
Current HIV Research Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued) Optimization on Fc for Improvement of Stability and Aggregation Resistance
Current Pharmaceutical Biotechnology The Causes and Consequences of Childhood Encephalitis in Asia
Infectious Disorders - Drug Targets Melatonin in Bacterial and Viral Infections with Focus on Sepsis: A Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Dengue Fever: Theories of Immunopathogenesis and Challenges for Vaccination
Inflammation & Allergy - Drug Targets (Discontinued) Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers
Current Pharmaceutical Design